PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Bicalutamide - Prostate cancer
PAD Profile : Bicalutamide - Prostate cancer
Brand Names Include :
Casodex
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Bicalutamide has been considered by the PCN and has been assigned a BLUE traffic light status. Note added January 2025 - this drug should be prescribed on recommendation from a specialist.
NOTE - the branded product, Casodex, was considered BLACK at the PCN in May 2017.
Associated BNF Codes
08. Malignant Disease and Immunosuppression
08.03.04. Hormone antagonists